| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |